Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/20482
Title: Cytotoxic function of gamma delta (/) T cells against pamidronate- treated cervical cancer cells
Authors: Lertworapreecha, Monthon
Patumraj, Suthiluk
Niruthisard, Somchai
Hansasuta, Pokrath
Bhattarakosol, Parvapan
Keywords: Cervical cancer;Gamma-delta T cells;Pamidronate;Immunotherapy
Issue Date: Aug-2013
Publisher: NISCAIR-CSIR, India
Abstract: The cytotoxic function of polyclonal expanded / T cells against pamidronate-treated cervical cancer cells in vitro and in vivo were determined. The / T cells were isolated and purified from PBMCs by using miniMACS and were later treated with 10 μM pamidronate. The expansion of / T cells was 15 times more than the non-stimulated cells. Among the expanded / T cells, 47% were V9/V2 T cells with a purity of 87%. Analyzing the cytotoxic function of / T cells against 3 cervical cancer cells in vitro by LDH cytotoxicity test revealed that the killing efficacy increased if the cervical cancer cells (HeLa, SiHa and CaSki) were pretreated with pamidronate. The presence of CD107 on / T cells indicated the degranulation of perforin and granzyme pathway is one of the mechanisms used by the / T cells to kill cancer cells. The killing ability of / T cells against cancer cells in vivo was preliminary assessed by using mouse baring HeLa cells. The results demonstrated that / T cells induce apoptosis in tumor cells. Our study supports the usefulness of / T cells in future development of immunotherapy for cervical cancer.
Page(s): 597-605
URI: http://hdl.handle.net/123456789/20482
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.51(08) [August 2013]

Files in This Item:
File Description SizeFormat 
IJEB 51(8) 597-605.pdf555.18 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.